DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $283,000 | +26.9% | 17,952 | -1.6% | 0.00% | – |
| Q2 2018 | $223,000 | +28.2% | 18,244 | 0.0% | 0.00% | – |
| Q1 2018 | $174,000 | +5.5% | 18,244 | 0.0% | 0.00% | – |
| Q4 2017 | $165,000 | +5.1% | 18,244 | -33.3% | 0.00% | – |
| Q3 2017 | $157,000 | +53.9% | 27,342 | -14.6% | 0.00% | – |
| Q2 2017 | $102,000 | -19.0% | 32,024 | -13.4% | 0.00% | – |
| Q1 2017 | $126,000 | +18.9% | 36,978 | 0.0% | 0.00% | – |
| Q4 2016 | $106,000 | -47.5% | 36,978 | +7.9% | 0.00% | – |
| Q3 2016 | $202,000 | +96.1% | 34,273 | 0.0% | 0.00% | – |
| Q2 2016 | $103,000 | -18.9% | 34,273 | +44.9% | 0.00% | – |
| Q1 2016 | $127,000 | -15.3% | 23,657 | +87.6% | 0.00% | – |
| Q4 2015 | $150,000 | – | 12,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |